Literature DB >> 7489740

Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10.

G M Crisi1, L Santambrogio, G M Hochwald, S R Smith, J A Carlino, G J Thorbecke.   

Abstract

A study was made of the ability of the superantigen staphylococcal enterotoxin B (SEB) to induce relapses of experimental allergic encephalomyelitis (EAE) in SJL mice that had partially or completely recovered from acute EAE. We find that a single injection of 0.05 mg SEB i.v. induces mild relapses in 50% of such mice. In addition, tumor necrosis factor (TNF)-alpha (0.2 micrograms, i.p.) also induces EAE relapses in 43% of SJL mice when injected 1-2 months after recovery. SEB does not induce a second relapse if reinjected when V beta 17a+T cells are still partially deleted. In these mice, however, TNF-alpha is equally effective in inducing relapses as in mice that did not receive SEB previously. We showed earlier that transforming growth factor (TGF)-beta and TNF-alpha have antagonistic effects on experimental autoimmune diseases; e.g., in spontaneously relapsing EAE, TGF-beta and anti-TNF were protective, while anti-TGF-beta caused disease exacerbation. Interleukin (IL)-10 is also known to counteract certain TNF effects. We now find that both human IL-10 and TGF-beta 2 lower the incidence of EAE relapses when given simultaneously with SEB or TNF-alpha. The protective effect of TGF-beta is significant only against relapses induced by SEB (reduced to 9%), and that of IL-10 only against relapses induced by TNF (reduced to 0%) with the treatment regimens employed. Neutralizing anti-TGF-beta does not increase the incidence of SEB-induced EAE relapses. In contrast, anti-IL-10 increases both the incidence and the severity of such relapses. We conclude that TNF production is probably important in causing EAE relapses, but that other aspects of the SEB-induced reactivation of myelin-specific T cells also contribute. Furthermore, endogenous IL-10 rather than TGF-beta production appears to limit the susceptibility to induction of EAE relapses in this model.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489740     DOI: 10.1002/eji.1830251108

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

Review 1.  The role of TNFalpha and lymphotoxin in demyelinating disease.

Authors:  C Lock; J Oksenberg; L Steinman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray.

Authors:  Silvia Mandel; Edna Grünblatt; Gila Maor; Moussa B H Youdim
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  Linkage of cytokine genes to rheumatoid arthritis. Evidence of genetic heterogeneity.

Authors:  S John; A Myerscough; A Marlow; A Hajeer; A Silman; W Ollier; J Worthington
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

4.  Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat.

Authors:  T Smith; A K Hewson; C I Kingsley; J P Leonard; M L Cuzner
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

5.  IL-5 induces proliferation and activation of microglia via an unknown receptor.

Authors:  S M Liva; J de Vellis
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

Review 6.  Gender issues and multiple sclerosis.

Authors:  Rhonda R Voskuhl
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 7.  Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.

Authors:  Tobias D Merson; Michele D Binder; Trevor J Kilpatrick
Journal:  Neuromolecular Med       Date:  2010-03-30       Impact factor: 3.843

8.  Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.

Authors:  Yoh Matsumoto; Il-Kwon Park; Keiko Hiraki; Shin Ohtani; Kuniko Kohyama
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

Review 9.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

10.  Abnormal Tr1 differentiation in multiple sclerosis.

Authors:  Anne L Astier; David A Hafler
Journal:  J Neuroimmunol       Date:  2007-10-22       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.